A research programme on remote measurement technology for #ADHD: using wearables & smartphones to study and improve outcomes | Led by Jonna Kuntsi & @richdobson
The ADHD Remote Technology (ART) group has made the move to Bluesky!🌟
Follow us there for updates on our ADHD research: https://t.co/LDQI2TcaUC
Looking forward to connecting in our new space!😊
#HereWeGo 🚨new paper🚨
"Consumer wearable devices for evaluation of heart rate control using digoxin versus beta-blockers: the RATE-AF randomized trial"
#mHealth#decentralizedtrials#atrialfibrillation @fitbit
https://t.co/6rjQWr6jDt
New #Postdoc opportunity in London! Come and work with Valdas Noreika, @MarghMalanchini & me @QM_SBBS on a new project on sleep and sensory sensitivity in adults with intellectual disability. Apply by 21 July👇
https://t.co/V0dTpVpeO6
Dobzhansky Award Memorial Presentation for Prof Peter McGuffin given by @anita_thapar1, with a beautiful performance by the Heath String Quartet of a piece composed by Peter. Very touching. Thank you to Prof Robert Plomin for organising @SGDPCentreKCL@KingsIoPPN
Great to see this paper with our MAP https://t.co/ybupOVdT1f findings, exploring health risks with ADHD from the perspectives of multiple stakeholders
@NIHRSPCR @ADHDFoundation @GeorginaSPCR @ashmoore2009 @ChYMe_Exe@ukaan
🎙️ Exciting news! Our 2️⃣nd podcast episode is live! @hoven_nina, Executive Director of #ADHD Liitto and elected President of @ADHD_Europe shares insights on how ADHD is managed in Finland and future steps for ADHD associations.
Tune in! 🎧 https://t.co/EZuwM7Zf3m
@UK_ADHD
We received a huge number of applications for our RA posts & look forward to inviting candidates for interviews soon!
The RAs will join postdoc @AshBowler - plus a large team of senior investigators and partners - on our new project on ADHD and transition to adulthood 👇
What does the transition to #adulthood look like for individuals with #ADHD? Prof Jonna Kuntsi talks about the ADHD Remote Technology research programme:
@ADHD_RemoteTech@KingsIoPPN
https://t.co/I0F3m4Mit0
➡️"This systematic review and meta-analysis found that symptom improvement with placebo treatment was substantial in all conditions"
ADHD among the conditions that showed pooled pre-post placebo effect sizes of 0.68-0.92
Most viewed in the last 7 days from @JAMAPsych:
Which psychiatric disorder exhibits the strongest improvement associated with placebo treatment in randomized clinical trials?
https://t.co/1YJdtXiNXv
We're hiring!
We are looking for two Research Assistants to work on our new project on #ADHD Remote Technology and ADHD transition
Apply by 18 June ⬇️⬇️
Fascinating talk by @agnew_blais on women in ADHD in times of hormonal change and and great discussion for our journal club led by Chiara Caserini on inflammation, sleep problems and childhood ADHD 🌟
Next @eunethydis webinar will be on 'Treatment adherence and persistence issues in #ADHD and the impact of psychoeducation' by Dr Maite Ferrin. Open for all! ⬇️⬇️
Our next webinar will be given by Dr. Maite Ferrin! The webinar is open for all - please register in advance using the link below or scanning the QR code👇👇!
https://t.co/jxkHaJHCzz
I’m delighted to have been asked to be co-chair of the new @NHSEngland cross-sector ADHD Taskforce alongside @anita_thapar1.
It will provide the chance for national partners to work together to ensure services meet the needs of those with ADHD.⬇️
https://t.co/BAsRSilVlE
Thank you to everyone who joined us at the #IACAPAP2024 World Congress! 🧠 Your presence made it a truly special time! 💙
📷 Dr. Guilherme V. Polanczyk and Dr. Luis Augusto Paim Rohde
The risks associated with having #ADHD
This umbrella review is the first comprehensive review to shed light on the extensive mental health, physical health and societal implications of #adhd
This review was a beast of a publication with amazing co-authors & so proud it is out!